Survival outcomes in duodenal carcinoma based on facility type: A National Cancer Database analysis. A phase II basket trial of dual anti–CTLA-4 and anti–PD-1 blockade in rare tumors (DART SWOG 1609) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results